Working with TipRanks
Follow Us
Stock Ideas
Daily Updates
Calendars
Education
About Us
Working with TipRanks
Follow Us
Agios Pharma (GB:0HB0)
LSE:0HB0
Agios Pharma (0HB0) Stock Price & Analysis
0 Followers
0HB0 Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$17.09 - $34.57
Previous Close$25.68
Volume162.00
Average Volume (3M)156.00
Market Cap
$1.44B
Enterprise Value$778.23M
Total Cash (Recent Filing)$739.20M
Total Debt (Recent Filing)$82.34M
Price to Earnings (P/E)N/A
Beta-0.64
Next Earnings
Aug 03, 2023EPS Estimate
-$1.56Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding55,580,791
10 Day Avg. Volume35
30 Day Avg. Volume156
Standard Deviation0.16
R-Squared0.28
Alpha0.00287
Financial Highlights & Ratios
Price to Book (P/B)1.42
Price to Sales (P/S)469.93
Price to Cash Flow (P/CF)-3.80
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue52.92
Enterprise Value/Gross Profit62.08
Enterprise Value/Ebitda-2.86
Forecast
1Y Price Target
$38.75Price Target Upside50.90% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering4
Agios Pharma News
0HB0 FAQ
What was Agios Pharma’s price range in the past 12 months?
Agios Pharma lowest stock price was $17.09 and its highest was $34.57 in the past 12 months.
What is Agios Pharma’s market cap?
Currently, no data Available
When is Agios Pharma’s upcoming earnings report date?
Agios Pharma’s upcoming earnings report date is Aug 03, 2023 which is in 66 days.
How were Agios Pharma’s earnings last quarter?
Agios Pharma released its earnings results on May 04, 2023. The company reported -$1.47 earnings per share for the quarter, beating the consensus estimate of -$1.701 by $0.231.
Is Agios Pharma overvalued?
According to Wall Street analysts Agios Pharma’s price is currently Undervalued.
Does Agios Pharma pay dividends?
Agios Pharma does not currently pay dividends.
What is Agios Pharma’s EPS estimate?
Agios Pharma’s EPS estimate is -$1.56.
How many shares outstanding does Agios Pharma have?
Currently, no data Available
What happened to Agios Pharma’s price movement after its last earnings report?
Agios Pharma reported an EPS of -$1.47 in its last earnings report, beating expectations of -$1.701. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Agios Pharma?
Among the largest hedge funds holding Agios Pharma’s share is Farallon Capital Management, L.L.C.. It holds Agios Pharma’s shares valued at 48M.
---
Agios Pharma Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$38.75 (50.90% Upside)
$38.75 (50.90% Upside)
Blogger Sentiment
Bullish
GB:0HB0 Sentiment 100%
Sector Average 70%
Sector Average 70%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
33.16%
12-Months-Change
Fundamentals
Return on Equity
-19.43%
Trailing 12-Months
Asset Growth
-13.82%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Agios Pharma
Agios Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the discovery and development of novel investigational medicines to treat cancer and rare genetic diseases. It focuses on diseases that are directly caused by changes in genes or chromosomes, often passed from one generation to the next. The company was founded by Lewis Clayton Cantley, Tak W. Mak, Craig B. Thompson and Shin-Shan Michael Su on August 7, 2007 and is headquartered in Cambridge, MA.
---
Catalyst Pharma
―
Prime Medicine, Inc.
―
Recursion Pharmaceuticals
―
Celldex
―
Immunovant
―
---